{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:19:55Z","timestamp":1791400795485,"version":"4.3.3"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1097\/dbp.0b013e31817dc447","type":"journal-article","created":{"date-parts":[[2008,8,7]],"date-time":"2008-08-07T03:06:43Z","timestamp":1218078403000},"page":"293-302","source":"Crossref","is-referenced-by-count":194,"title":["Open-Label Treatment Trial of Lithium to Target the Underlying Defect in Fragile X Syndrome"],"prefix":"10.1097","volume":"29","author":[{"given":"Elizabeth","family":"Berry-Kravis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Sumis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Hervey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Porges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Jeanne","family":"Weiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Greenough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210129","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G","article-title":"Prevalence of fragile X syndrome.","volume":"64","author":"Turner","year":"1996","journal-title":"Am J Med Genet"},{"issue":"11","key":"R2-7-20210129","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1469-8749.2002.tb00277.x","article-title":"Epilepsy in fragile X syndrome.","volume":"44","author":"Berry-Kravis","year":"2002","journal-title":"Dev Med Child Neurol"},{"key":"R3-7-20210129","first-page":"3","article-title":"Fragile X Syndrome: Diagnosis, Treatment and Research. 2nd ed.","author":"Hagerman","year":"1996"},{"key":"R4-7-20210129","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1054\/cupe.2002.0305","article-title":"Fragile X syndrome.","volume":"2","author":"Berry-Kravis","year":"2002","journal-title":"Current Pediatrics"},{"key":"R5-7-20210129","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","article-title":"Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.","volume":"65","author":"Verkerk","year":"1991","journal-title":"Cell"},{"key":"R6-7-20210129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng0893-335","article-title":"The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation.","volume":"4","author":"Devys","year":"1993","journal-title":"Nature Genetics"},{"key":"R7-7-20210129","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1523\/JNEUROSCI.1790-06.2006","article-title":"Local protein synthesis and spine morphogenesis: fragile X syndrome and beyond.","volume":"26","author":"Grossman","year":"2006","journal-title":"J Neurosci"},{"key":"R8-7-20210129","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nrn1667","article-title":"From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome.","volume":"6","author":"Bagni","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"R9-7-20210129","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1523\/JNEUROSCI.0099-04.2004","article-title":"Metabotropic glutamate receptor activation regulates fragile X mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses.","volume":"24","author":"Antar","year":"2004","journal-title":"J Neurosci"},{"key":"R10-7-20210129","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1073\/pnas.0409803102","article-title":"The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain.","volume":"102","author":"Aschrafi","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"R11-7-20210129","doi-asserted-by":"crossref","first-page":"17329","DOI":"10.1073\/pnas.0407533101","article-title":"Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses.","volume":"101","author":"Weiler","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R12-7-20210129","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1073\/pnas.122205699","article-title":"Altered synaptic plasticity in a mouse model of fragile X mental retardation.","volume":"99","author":"Huber","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"R13-7-20210129","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neuron.2005.07.005","article-title":"Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines and attenuates cerebellar eyelid conditioning in fragile X syndrome.","volume":"47","author":"Koekkoek","year":"2005","journal-title":"Neuron"},{"key":"R14-7-20210129","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/mcne.2001.1085","article-title":"Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency.","volume":"19","author":"Li","year":"2002","journal-title":"Mol Cell Neurosci"},{"key":"R15-7-20210129","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","article-title":"The mGluR theory of fragile X mental retardation.","volume":"27","author":"Bear","year":"2004","journal-title":"Trends Neurosci"},{"key":"R16-7-20210129","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ajmg.10500","article-title":"Dendritic spine and dendritic field characteristics of later V pyramidal neurons in the visual cortex of fragile X-knockout mice.","volume":"111","author":"Irwin","year":"2002","journal-title":"Am J Med Genet"},{"key":"R17-7-20210129","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1523\/JNEUROSCI.1777-05.2005","article-title":"Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model.","author":"Chuang","year":"2005","journal-title":"J Neurosci"},{"key":"R18-7-20210129","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1601-183X.2005.00135.x","article-title":"Therapeutic implications of the mGluR theory of fragile X mental retardation.","volume":"4","author":"Bear","year":"2005","journal-title":"Genes Brain Behav"},{"key":"R19-7-20210129","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.neuropharm.2005.06.004","article-title":"Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.","volume":"49","author":"Yan","year":"2005","journal-title":"Neuropharmacology"},{"key":"R20-7-20210129","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.neuron.2005.01.038","article-title":"Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a model of fragile X syndrome.","volume":"45","author":"McBride","year":"2005","journal-title":"Neuron"},{"key":"R21-7-20210129","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1001\/jama.1989.03430130110043","article-title":"The Albert Lasker Medical Awards. Inositol trisphosphate, calcium, lithium, and cell signaling.","volume":"262","author":"Berridge","year":"1989","journal-title":"JAMA"},{"key":"R22-7-20210129","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/361315a0","article-title":"Inositol trisphosphate and calcium signalling.","volume":"361","author":"Berridge","year":"1993","journal-title":"Nature"},{"key":"R23-7-20210129","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1126\/science.282.5394.1705","article-title":"Regulation of nerve growth mediated by inositol 1,4,5-trisphosphate receptors in growth cones.","volume":"282","author":"Takei","year":"1998","journal-title":"Science"},{"key":"R24-7-20210129","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1023\/B:NERE.0000042220.16373.29","article-title":"Calcium-dependent protein kinase C activation in acutely isolated neurons during oxygen and glucose deprivation.","volume":"29","author":"Larsen","year":"2004","journal-title":"Neurochem Res"},{"key":"R26-7-20210129","first-page":"287","article-title":"Fragile X Syndrome: Diagnosis, Treatment and Research. 3rd ed.","author":"Hagerman","year":"2002"},{"key":"R27-7-20210129","article-title":"Aberrant Behavior Checklist \u2013 Community.","author":"Aman","year":"1994"},{"key":"R28-7-20210129","article-title":"Stanford-Binet Intelligence Scales, Fifth Edition Manual.","author":"Roid","year":"2003"},{"key":"R29-7-20210129","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems.","volume":"347","author":"McCracken","year":"2002","journal-title":"N Engl J Med"},{"key":"R30-7-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jpepsy\/10.2.215","article-title":"Diagnostic uses of the Vineland Adaptive Behavior Scales.","volume":"10","author":"Sparrow","year":"1985","journal-title":"J Pediatr Psychol"},{"key":"R31-7-20210129","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/cap.2006.16.525","article-title":"Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial.","volume":"16","author":"Berry-Kravis","year":"2006","journal-title":"J Child Adolescent Psychpharm"},{"key":"R33-7-20210129","article-title":"Peabody Picture Vocabulary Test. 3rd ed.","author":"Dunn","year":"1987"},{"key":"R34-7-20210129","article-title":"Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).","author":"Randolph","year":"1998"},{"key":"R35-7-20210129","article-title":"NEPSY: A Developmental Neuropsychological Assessment.","author":"Korkman","year":"1998"},{"key":"R36-7-20210129","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.pnpbp.2004.12.015","article-title":"Age-associated cognitive deficits in humans and dogs: a comparative neuropsychological approach.","volume":"29","author":"Boutet","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R37-7-20210129","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ajmg.b.30504","article-title":"Sustained attention and response inhibition in boys with fragile X syndrome: measures of continuous performance.","volume":"144","author":"Sullivan","year":"2007","journal-title":"Am J Med Genet"},{"key":"R40-7-20210129","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1126\/science.1100021","article-title":"Protein kinase C overactivity impairs prefrontal cortical regulation of working memory.","volume":"306","author":"Birnbaum","year":"2004","journal-title":"Science"},{"key":"R41-7-20210129","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1469-7610.2004.t01-1-00297.x","article-title":"Deconstructing the attention deficit in fragile X syndrome: a developmental neuropsychological approach.","volume":"45","author":"Cornish","year":"2004","journal-title":"J Child Psychol Psychiatry"}],"container-title":["Journal of Developmental &amp; Behavioral Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004703-200808000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:11:34Z","timestamp":1786036294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004703-200808000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/dbp.0b013e31817dc447","relation":{},"ISSN":["0196-206X"],"issn-type":[{"value":"0196-206X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}